Astellas loses patent infringement case over blockbuster bladder drug
Astellas just faced a setback in federal court — with a judge invalidating three claims on a patent surrounding an extended release version of its blockbuster …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.